The authors have no relationships/conditions/circumstances that present a potential conflict of interest.
Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia
Version of Record online: 2 NOV 2011
© 2011 The Author(s)/Acta Pædiatrica © 2011 Foundation Acta Pædiatrica
Volume 101, Issue 3, pages 319–323, March 2012
How to Cite
Roka, A., Kelen, D., Halasz, J., Beko, G., Azzopardi, D. and Szabo, M. (2012), Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatrica, 101: 319–323. doi: 10.1111/j.1651-2227.2011.02480.x
The TOBY trial was supported by the United Kingdom Medical Research Council and the Department of Health.
- Issue online: 25 JAN 2012
- Version of Record online: 2 NOV 2011
- Accepted manuscript online: 7 OCT 2011 08:39AM EST
- Received 30 June 2011; revised 25 August 2011; accepted 3 October 2011.
Vol. 101, Issue 11, 1184, Version of Record online: 1 OCT 2012
Table S1 Anthropometric and clinical parameters of asphyxiated infants treated with systemic hypothermia or normothermia.
Table S2 Serum S100B and neuron-specific enolase (NSE) levels in asphyxiated infants treated with systemic hypothermia or normothermia.
Table S3 Serum S100B and neuron-specific enolase (NSE) levels in asphyxiated infants with no severe disability and infants with severe disability/death.
|APA_2480_sm_t1-3.doc||74K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.